MXPA05008748A - Inhibidores no nucleosidos de transcriptasa inversa. - Google Patents
Inhibidores no nucleosidos de transcriptasa inversa.Info
- Publication number
- MXPA05008748A MXPA05008748A MXPA05008748A MXPA05008748A MXPA05008748A MX PA05008748 A MXPA05008748 A MX PA05008748A MX PA05008748 A MXPA05008748 A MX PA05008748A MX PA05008748 A MXPA05008748 A MX PA05008748A MX PA05008748 A MXPA05008748 A MX PA05008748A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- group
- alkoxy
- optionally substituted
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44797403P | 2003-02-18 | 2003-02-18 | |
| PCT/EP2004/001477 WO2004074257A1 (en) | 2003-02-18 | 2004-02-17 | Non-nucleoside reverse transcriptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05008748A true MXPA05008748A (es) | 2005-09-20 |
Family
ID=32908518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05008748A MXPA05008748A (es) | 2003-02-18 | 2004-02-17 | Inhibidores no nucleosidos de transcriptasa inversa. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7241794B2 (enExample) |
| EP (1) | EP1597235B1 (enExample) |
| JP (1) | JP4608480B2 (enExample) |
| KR (1) | KR100776093B1 (enExample) |
| CN (1) | CN100389109C (enExample) |
| AR (1) | AR043195A1 (enExample) |
| AT (1) | ATE370124T1 (enExample) |
| BR (1) | BRPI0407591A (enExample) |
| CA (1) | CA2515151C (enExample) |
| CL (1) | CL2004000270A1 (enExample) |
| DE (1) | DE602004008227T2 (enExample) |
| ES (1) | ES2291854T3 (enExample) |
| MX (1) | MXPA05008748A (enExample) |
| PL (1) | PL378556A1 (enExample) |
| RU (1) | RU2305680C2 (enExample) |
| TW (1) | TW200423930A (enExample) |
| WO (1) | WO2004074257A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004099157A1 (en) * | 2003-05-07 | 2004-11-18 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
| RU2383536C2 (ru) | 2004-08-04 | 2010-03-10 | Тайсо Фармасьютикал Ко., Лтд. | Производное триазола |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| EP1988083B1 (en) | 2006-02-03 | 2014-04-02 | Taisho Pharmaceutical Co., Ltd. | Triazole derivative |
| US7994204B2 (en) | 2006-02-06 | 2011-08-09 | Taisho Pharmaceutical Co., Ltd | Binding inhibitor of sphingosine-1-phosphate |
| ES2381695T3 (es) * | 2006-02-14 | 2012-05-30 | Ihara Chemical Industry Co., Ltd. | Procedimiento para producir un compuesto 5-alcoxi-4-hidroximetilpirazol |
| CL2007002105A1 (es) * | 2006-07-21 | 2008-02-22 | Hoffmann La Roche | Compuestos derivados de 2-[3-(3-cianofenoxi)(fenoxi o fenilsulfanil)]-n-fenil acetamida, inhibidores de la transcriptasa inversa del vih; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar u |
| AU2007286345B2 (en) | 2006-08-16 | 2012-03-08 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
| CA2682637A1 (en) * | 2007-03-29 | 2008-10-09 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
| SI2177512T1 (sl) | 2007-08-01 | 2012-06-29 | Taisho Pharmaceutical Co Ltd | Inhibitor vezave S1P1 |
| JP5411160B2 (ja) * | 2007-12-21 | 2014-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | 複素環式抗ウイルス性化合物 |
| DE102008015033A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| MA34170B1 (fr) | 2010-03-30 | 2013-04-03 | Merck Canada Inc | Inhibiteurs de transcriptase inverse non nucléosidiques |
| JP5722891B2 (ja) | 2010-07-15 | 2015-05-27 | 大日本住友製薬株式会社 | ピラゾール化合物 |
| EP2508511A1 (en) | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| EP2822931B1 (en) | 2012-03-09 | 2017-05-03 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| KR20150023822A (ko) | 2012-06-20 | 2015-03-05 | 벤더르빌트 유니버시티 | Mglur5 수용체의 알로스테릭 조절물질로서 치환된 바이사이클릭 알콕시 피라졸 유사체 |
| WO2013192346A1 (en) | 2012-06-20 | 2013-12-27 | Vanderbilt University | Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| JP6404230B2 (ja) | 2012-12-20 | 2018-10-10 | インセプション ２、 インコーポレイテッド | トリアゾロン化合物およびその使用 |
| CA2921420A1 (en) | 2013-09-06 | 2015-03-12 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| CN106456639B (zh) | 2014-04-01 | 2019-05-10 | 默沙东公司 | Hiv逆转录酶抑制剂的前药 |
| AU2015317823A1 (en) | 2014-09-17 | 2017-03-23 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
| WO2016044445A2 (en) | 2014-09-17 | 2016-03-24 | Ironwood Pharmaceuticals, Inc. | sGC STIMULATORS |
| EP3271336A1 (en) * | 2015-03-19 | 2018-01-24 | E. I. du Pont de Nemours and Company | Fungicidal pyrazoles |
| EP3478665A1 (en) * | 2016-06-29 | 2019-05-08 | Esteve Pharmaceuticals, S.A. | Pyrazole derivatives having activity against pain |
| CN110818636A (zh) * | 2019-11-29 | 2020-02-21 | 河北科技大学 | 一种化合物或其盐及其应用和合成方法 |
| CN115677585B (zh) * | 2022-10-31 | 2024-03-19 | 上海群力化工有限公司 | 一种甲醛吡唑衍生物的合成工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0786455B1 (en) | 1994-09-26 | 2003-12-03 | Shionogi & Co., Ltd. | Imidazole derivative |
| DE19734664A1 (de) * | 1997-08-11 | 1999-02-18 | Bayer Ag | (Hetero)Aryloxypyrazole |
| GB0016787D0 (en) * | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
| US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| GB0024795D0 (en) * | 2000-10-10 | 2000-11-22 | Hoffmann La Roche | Pyrazole derivatives for the treatment of viral diseases |
| GB0028484D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Imidazolone derivatives for the treatment of viral diseases |
| EE05400B1 (et) * | 2001-04-10 | 2011-04-15 | Pfizer Inc. | Prasoolderivaadid, neid v?i nende farmatseutiliselt vastuv?etavaid sooli, solvaate v?i derivaate sisaldavad farmatseutilised kompositsioonid, nende kasutamine ning meetodid nende valmistamiseks |
| GB0113524D0 (en) * | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
-
2004
- 2004-02-12 TW TW093103358A patent/TW200423930A/zh unknown
- 2004-02-16 CL CL200400270A patent/CL2004000270A1/es unknown
- 2004-02-17 EP EP04711607A patent/EP1597235B1/en not_active Expired - Lifetime
- 2004-02-17 MX MXPA05008748A patent/MXPA05008748A/es active IP Right Grant
- 2004-02-17 ES ES04711607T patent/ES2291854T3/es not_active Expired - Lifetime
- 2004-02-17 WO PCT/EP2004/001477 patent/WO2004074257A1/en not_active Ceased
- 2004-02-17 KR KR1020057015085A patent/KR100776093B1/ko not_active Expired - Fee Related
- 2004-02-17 RU RU2005128832/04A patent/RU2305680C2/ru active
- 2004-02-17 CA CA2515151A patent/CA2515151C/en not_active Expired - Fee Related
- 2004-02-17 AT AT04711607T patent/ATE370124T1/de not_active IP Right Cessation
- 2004-02-17 DE DE602004008227T patent/DE602004008227T2/de not_active Expired - Lifetime
- 2004-02-17 BR BRPI0407591-9A patent/BRPI0407591A/pt not_active IP Right Cessation
- 2004-02-17 AR ARP040100477A patent/AR043195A1/es not_active Application Discontinuation
- 2004-02-17 JP JP2006500034A patent/JP4608480B2/ja not_active Expired - Fee Related
- 2004-02-17 PL PL378556A patent/PL378556A1/pl not_active Application Discontinuation
- 2004-02-17 CN CNB2004800044061A patent/CN100389109C/zh not_active Expired - Fee Related
- 2004-02-18 US US10/781,373 patent/US7241794B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE370124T1 (de) | 2007-09-15 |
| CL2004000270A1 (es) | 2005-02-04 |
| PL378556A1 (pl) | 2006-05-02 |
| EP1597235B1 (en) | 2007-08-15 |
| JP4608480B2 (ja) | 2011-01-12 |
| EP1597235A1 (en) | 2005-11-23 |
| KR100776093B1 (ko) | 2007-11-15 |
| WO2004074257A1 (en) | 2004-09-02 |
| ES2291854T3 (es) | 2008-03-01 |
| CN100389109C (zh) | 2008-05-21 |
| JP2006515339A (ja) | 2006-05-25 |
| US20040192666A1 (en) | 2004-09-30 |
| AU2004213134A1 (en) | 2004-09-02 |
| DE602004008227D1 (de) | 2007-09-27 |
| BRPI0407591A (pt) | 2006-02-14 |
| TW200423930A (en) | 2004-11-16 |
| DE602004008227T2 (de) | 2008-05-15 |
| CA2515151C (en) | 2010-11-30 |
| RU2305680C2 (ru) | 2007-09-10 |
| AR043195A1 (es) | 2005-07-20 |
| KR20050105471A (ko) | 2005-11-04 |
| RU2005128832A (ru) | 2006-04-27 |
| US7241794B2 (en) | 2007-07-10 |
| CA2515151A1 (en) | 2004-09-02 |
| CN1751028A (zh) | 2006-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05008748A (es) | Inhibidores no nucleosidos de transcriptasa inversa. | |
| TWI235752B (en) | Inhibitors of c-JUN N-terminal kinases (JNK) and other protein kinases | |
| JP4426660B2 (ja) | ピラゾール誘導体、その製法および医薬としてのその使用 | |
| CA2263417C (en) | Arylalkanoylpyridazines | |
| AU750019B2 (en) | Aryl alkanoylpyridazines | |
| US11001589B2 (en) | Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors | |
| NO334095B1 (no) | Ikke-Nukleoside Revers Transkriptase-Inhibitorer I for behandling av HIV-medierte sydommer | |
| NO326518B1 (no) | Pyrazolderivater og anvendelse derav, samt farmasoytisk sammensetning | |
| US6538015B1 (en) | Anti-HIV pyrazole derivatives | |
| US6737429B2 (en) | Pyrrole derivatives | |
| US20080287390A1 (en) | Pyrazolidinol compounds | |
| US9249148B2 (en) | Tris(hetero)arylpyrazoles and use thereof | |
| AU2004213134B2 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| MX2010008414A (es) | Heterociclos novedosos. | |
| AU6688300A (en) | Benzoylpyridazines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |